Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Current Leases (2020 - 2025)

Historic Current Leases for MDxHealth (MDXH) over the last 6 years, with Q3 2025 value amounting to $10.0 million.

  • MDxHealth's Current Leases rose 29511.23% to $10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year increase of 29511.23%. This contributed to the annual value of $7.4 million for FY2024, which is 40087.84% up from last year.
  • Latest data reveals that MDxHealth reported Current Leases of $10.0 million as of Q3 2025, which was up 29511.23% from $10.3 billion recorded in Q2 2025.
  • MDxHealth's 5-year Current Leases high stood at $10.3 billion for Q2 2025, and its period low was $840000.0 during Q4 2021.
  • Over the past 5 years, MDxHealth's median Current Leases value was $3.1 million (recorded in 2024), while the average stood at $736.4 million.
  • As far as peak fluctuations go, MDxHealth's Current Leases plummeted by 5211.91% in 2023, and later surged by 33140242.33% in 2025.
  • Over the past 5 years, MDxHealth's Current Leases (Quarter) stood at $840000.0 in 2021, then surged by 267.98% to $3.1 million in 2022, then tumbled by 52.12% to $1.5 million in 2023, then soared by 400.88% to $7.4 million in 2024, then skyrocketed by 35.22% to $10.0 million in 2025.
  • Its last three reported values are $10.0 million in Q3 2025, $10.3 billion for Q2 2025, and $7.1 million during Q1 2025.